This study aimed to assess the expression of NCAPH in human breast cancer, and to investigate its effects on breast cancer cells.
Bioinformation analysis was performed to analyze the expression of NCAPH in human breast cancer tissues and normal tissues in TCGA database. qPCR and Immunoblot assays were performed to clarify the expression of NCAPH in breast cancer tissues and cell lines, respectively. CCK-8, colony formation, FCM, transwell, and immunoblot assays were performed to reveal the effects of NCAPH on breast cancer proliferation, cell cycle, motility and EMT of breast cancer cells. Additionally, immunoblot assays were performed to investigate the effects of NCAPH on the PI3K/AKT pathway in breast cancer.
We found that NCAPH was highly expressed in human breast cancer cell lines. The depletion of NCAPH suppressed the viability of breast cancer cells. Further, we noticed that its downregulation restrained breast cancer cell migration as well as invasion, and the EMT process. Mechanically, we noticed that NCAPH mediated the PI3K/AKT pathway, and therefore contributed to breast cancer progression.
In summary, NCAPH has the potential to serve as a breast cancer target.
Romero-Cordoba S , Tagliabue E , Triulzi T , Bianchi F . Deep into breast cancer heterogeneity to increase immunotherapeutic effectiveness. JCO Precis Oncol 2020; 4: 1267–8. https://doi.org/10.1200/PO.20.00313.
Park JH , Han HS , Lim SD , Kim WY , Park KS , Yoo YB , et al. Fatty acid synthetase expression in triple-negative breast cancer. J Pathol Transl Med 2022; 56(2): 73–80. https://doi.org/10.4132/jptm.2021.10.27.
Ahearn TU , Zhang H , Michailidou K , Milne RL , Bolla MK , Dennis J , et al. Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Res 2022; 24(1): 2. https://doi.org/10.1186/s13058-021-01484-x.
Camilloni A , Nati G , Maggiolini P , Romanelli A , Carbone G , Giannarelli D , et al. Chronic non-cancer pain in primary care: An Italian cross-sectional study. Signa Vitae 2021; 17(2): 54–62. https://doi.org/10.22514/sv.2020.16.0111.
Yang ZY , Yin SP , Ren Q , Lu DW , Tang T , Li Y , et al. BAHD1 serves as a critical regulator of breast cancer cell proliferation and invasion. Breast Cancer 2022; 29(3): 516–30. https://doi.org/10.1007/s12282-022-01333-5.
Dai R , Peng X , Lin B , Xu D , Lv R . NIR II Luminescence imaging for sentinel lymph node and enhanced chemo-/photothermal therapy for breast cancer. Bioconjug Chem 2021; 32(9): 2117–27. https://doi.org/10.1021/acs.bioconjchem.1c00393.
Hickey BE , Lehman M . Partial breast irradiation versus whole breast radiotherapy for early breast cancer. Cochrane Database Syst Rev 2021; 8: CD007077. https://doi.org/10.1002/14651858.CD007077.pub4.
Karahaliloglu Z , Kilicay E , Hazer B . Herceptin-conjugated magnetic polystyrene-Agsbox nanoparticles as a theranostic agent for breast cancer. J Biomater Appl 2022; 36(9): 1599–616. https://doi.org/10.1177/08853282211065085.
Li B , Xiao Q , Shan L , Song Y . NCAPH promotes cell proliferation and inhibits cell apoptosis of bladder cancer cells through MEK/ERK signaling pathway. Cell Cycle 2022; 21(4): 427–38. https://doi.org/10.1080/15384101.2021.2021050.
Wang Y , Li JQ , Yang ZL , Wang L , Zhang JC , Sun YF , et al. NCAPH regulates gastric cancer progression through DNA damage response. Neoplasma 2022; 69(2): 283–91. https://doi.org/10.4149/neo_2021_210607N761.
Ryu B , Kim DS , Deluca AM , Alani RM . Comprehensive expression profiling of tumor cell lines identifies molecular signatures of melanoma progression. PLoS One 2007; 2(7): e594. https://doi.org/10.1371/journal.pone.0000594.
Kim B , Kim SW , Lim JY , Park SJ . NCAPH is required for proliferation, migration and invasion of non-small-cell lung cancer cells. Anticancer Res 2020; 40(6): 3239–46. https://doi.org/10.21873/anticanres.14305.
Cui F , Hu J , Xu Z , Tan J , Tang H . Overexpression of NCAPH is upregulated and predicts a poor prognosis in prostate cancer. Oncol Lett 2019; 17(6): 5768–76. https://doi.org/10.3892/ol.2019.10260.
Yin L , Jiang LP , Shen QS , Xiong QX , Zhuo X , Zhang LL , et al. NCAPH plays important roles in human colon cancer. Cell Death Dis 2017; 8(3):e2680. https://doi.org/10.1038/cddis.2017.88.
Wang M , Qiao X , Cooper T , Pan W , Liu L , Hayball J , et al. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway. Cell Death Dis 2020; 11(12): 1049. https://doi.org/10.1038/s41419-020-03244-9.
Lu H , Shi C , Wang S , Yang C , Wan X , Luo Y , et al. Identification of NCAPH as a biomarker for prognosis of breast cancer. Mol Biol Rep 2020; 47(10): 7831–42. https://doi.org/10.1007/s11033-020-05859-9.
Bilgilier C , Fuereder T , Kastner MT , Vass Z , Brandl I , Sahbegovic H , et al. Oral abundance of Actinomyces spp. in breast cancer patients. Oncology 2022; 100(4): 221–7. https://doi.org/10.1159/000522070.
Tang L , Jiang W , Wu L , Yu X , He Z , Shan W , et al. TPGS2000-DOX prodrug micelles for improving breast cancer therapy. Int J Nanomedicine 2021; 16: 7875–90. https://doi.org/10.2147/IJN.S335405.
Qi Y , Zhao T , Han M . The application of radiomics in predicting gene mutations in cancer. Eur Radiol 2022; 32(6): 4014–24. https://doi.org/10.1007/s00330-021-08520-6.
Xiong Q , Fan S , Duan L , Liu B , Jiang X , Chen X , et al. NCAPH is negatively associated with Mcl1 in nonsmall cell lung cancer. Mol Med Rep 2020; 22(4): 2916–24. https://doi.org/10.3892/mmr.2020.11359.
Shimomura H , Sasahira T , Nakashima C , Kurihara-Shimomura M , Kirita T . Non-SMC condensin I complex subunit H (NCAPH) is associated with lymphangiogenesis and drug resistance in oral squamous cell carcinoma. J Clin Med 2019; 9(1): 72. https://doi.org/10.3390/jcm9010072.
Kim JH , Youn Y , Kim KT , Jang G , Hwang JH . Non-SMC condensin I complex subunit H mediates mature chromosome condensation and DNA damage in pancreatic cancer cells. Sci Rep 2019; 9(1): 17889. https://doi.org/10.1038/s41598-019-54478-3.
Li H , Chen M , Yang Z , Xu C , Yu Q , Song J , et al. Amorphophalli Rhizoma inhibits breast cancer growth, proliferation, migration, and invasion via the PI3K/AKT pathway. J Ethnopharmacol 2022; 286: 114926. https://doi.org/10.1016/j.jep.2021.114926.
Li J , Zhang C , Jiang H , Cheng J . Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth. Onco Targets Ther 2015; 8: 427–35. https://doi.org/10.2147/OTT.S76116.